This technology is comprised of a mouse monoclonal antibody that specifically recognizes human EAF1, a protein of approximately 45 kDa. It has been meticulously validated for multiple applications, including Western Blot—using a 1:10,000 dilution for transfected proteins and a 1:1,000 dilution for endogenous proteins—and for immunoprecipitation protocols. Developed in parallel with a similar, yet distinct, antibody from another hybridoma, this tool showcases high specificity to human EAF1 with no confirmed cross-reactivity with proteins from other species. Comprehensive in vitro data and NIH-supported research further underpin its credibility.
Description
This approach stands out due to its tailored dilution recommendations and reproducible performance, addressing limitations found in previous commercial options. Its dual capacity for detecting both transfected and native forms of the protein facilitates more precise molecular analyses. Supported by robust research grants and published findings, the method's specificity and differential performance underscore its value for researchers focusing on EAF1 cellular functions, thereby streamlining investigative workflows in molecular biology.
Applications
- EAF1 Western blot reagent
- EAF1 immunoprecipitation tool
- Molecular biology research antibody
Advantages
- High specificity for human EAF1 without confirmed cross-reactivity to other species
- Versatile applications including optimized Western Blot and immunoprecipitation protocols
- Validated performance with precise dilution recommendations for both transfected and endogenous proteins
- Reproducible antibody production using parallel hybridoma approaches ensuring consistent results
- Supported by robust in vitro testing and NIH-funded research, enhancing reliability for research applications
IP Status
Research Tool
